Bạn đang xem bản rút gọn của tài liệu. Xem và tải ngay bản đầy đủ của tài liệu tại đây (133.68 KB, 1 trang )
CLINICAL PEARLS AND PITFALLS
Acute decompensations are most commonly seen with tyrosinemia, organic acidemias, urea
cycle defects, fatty acid oxidation defects, and galactosemia.
Early recognition of acute metabolic decompensation is critical for effective management of
patients with known IEM.
A history of physiologic stress, such as intercurrent illness or recent surgery, or
noncompliance with diet may precipitate symptoms and warrants preventative management.
Current Understanding
Manifestations of IEM are disease specific but also patient specific. Understanding of these specifics, as
well as advances in treatment, will most expeditiously and effectively guide evaluation and management.
Clinical Considerations
Triage
Patients with known IEM associated with potential for acute life-threatening decompensation should be
triaged expeditiously. Many families have treatment pathways in hand (or delineated in EMR) to
optimize care ( Table 95.8 ).
AMINO ACID DISORDERS
Goals of Treatment
Treatment of children with amino acid disorders includes avoiding dietary intake of the offending amino
acid(s), and correcting acute metabolic and physiologic derangements.
Current Understanding
Most amino acid disorders do not cause acute decompensation. A notable exception is tyrosinemia type I,
a disorder of phenylalanine and tyrosine metabolism that initially causes liver failure and later
hepatocellular carcinoma. It usually presents in early infancy but can present in the neonatal period.
Clinical Considerations
Assessment
Clinical features include lethargy, vomiting, diarrhea, failure to thrive, hypoglycemia, jaundice, ascites,